Tranexamic Acid
NDC 72319-028, Tranexamic Acid, tablet, from i3 Pharmaceuticals, LLC.
- Product NDC
- 72319-028
- Status
- Listed
- Labeler
- i3 Pharmaceuticals, LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA219702
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72319-028 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TRANEXAMIC ACID650 mg/1
Pharmacologic classes
Antifibrinolytic Agent [EPC]; Decreased Fibrinolysis [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72319-028-01 | 72319002801 | 30 TABLET in 1 BOTTLE, PLASTIC (72319-028-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/2c48c13a-5e7d-43ef-81a3-27d3bcda0f80
Use it
Look up 72319-028 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72319-028 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72319-028. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.